{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T02:47:38Z","timestamp":1774147658505,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.ypmed.2015.07.015","type":"journal-article","created":{"date-parts":[[2015,7,26]],"date-time":"2015-07-26T13:29:24Z","timestamp":1437917364000},"page":"18-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Caring for pregnant opioid abusers in Vermont: A potential model for non-urban areas"],"prefix":"10.1016","volume":"80","author":[{"given":"Marjorie","family":"Meyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2015.07.015_bb0005","author":"American Association for the Treatment of Opioid Dependence"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10550887.2012.694598","article-title":"Maintenance medication for opiate addiction: the foundation of recovery","volume":"31","author":"Bart","year":"2012","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.ypmed.2015.07.015_bb0015","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0027-9684(15)30175-9","article-title":"Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options","volume":"104","author":"Bonhomme","year":"2012","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.ypmed.2015.07.015_bb0020","first-page":"464","article-title":"Predictors of neonatal outcomes amongst a methadone- and\/or heroin-dependent population referred to a multidisciplinary Perinatal and Family Drug Health Service","volume":"53","author":"Buckley","year":"2013","journal-title":"Aust. NZ J. Obstet. Gynecol."},{"key":"10.1016\/j.ypmed.2015.07.015_bb0025","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","article-title":"The changing face of heroin use in the United States: a retrospective analysis of the past 50years","volume":"71","author":"Cicero","year":"2014","journal-title":"JAMA psychiatry"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder: review of the evidence and future directions","volume":"23","author":"Connery","year":"2015","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0035","first-page":"3019","article-title":"Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians","volume":"15","author":"DeFlavio","year":"2015","journal-title":"Rural Remote Health"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0040","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/add.12863","article-title":"Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006\u201310","volume":"110","author":"Evans","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0045","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/jamainternmed.2014.5302","article-title":"Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial","volume":"174","author":"Fiellin","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.ypmed.2015.07.015_bb0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1749-6632.1978.tb16770.x","article-title":"Management of pregnant drug dependent women","volume":"311","author":"Finnegan","year":"1978","journal-title":"NYAS"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1360-0443.2000.95223910.x","article-title":"Treatment of opioid-dependent pregnant women with buprenorphine","volume":"95","author":"Fischer","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0060","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.2105\/AJPH.2013.301299","article-title":"The RE-AIM framework: a systematic review of use over time","volume":"103","author":"Gaglio","year":"2013","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0065","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jsat.2013.11.002","article-title":"Mobile opioid agonist treatment and public funding expands treatment for disenfranchised opioid-dependent individuals","volume":"46","author":"Hall","year":"2014","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.ypmed.2015.07.015_bb0070","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.drugalcdep.2013.02.031","article-title":"Induction of pregnant women onto opioid-agonist maintenance medication: an analysis of withdrawal symptoms and study retention","volume":"132","author":"Holbrook","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ypmed.2015.07.015_bb0075","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1370\/afm.1595","article-title":"Barriers to primary care physicians prescribing buprenorphine","volume":"12","author":"Hutchinson","year":"2014","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.ypmed.2015.07.015_bb0090","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2015.07.015_bb0085","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2165\/11632820-000000000-00000","article-title":"Methadone and buprenorphine for the management of opioid dependence in pregnancy","volume":"72","author":"Jones","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0080","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1360-0443.2012.03811.x","article-title":"Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research","volume":"108","author":"Jones","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0095","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","article-title":"Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial","volume":"377","author":"Krupitsky","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0100","first-page":"CD002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ypmed.2015.07.015_bb0105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/ADM.0b013e3182541933","article-title":"Development of a substance abuse program for opioid-dependent nonurban pregnant women improves outcome","volume":"6","author":"Meyer","year":"2012","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.ypmed.2015.07.015_bb0110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/ADM.0000000000000092","article-title":"Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study","volume":"9","author":"Meyer","year":"2015","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.ypmed.2015.07.015_bb0115","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/10550880903014767","article-title":"Diversion of buprenorphine\/naloxone coformulated tablets in a region with high prescribing prevalence","volume":"28","author":"Monte","year":"2009","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.ypmed.2015.07.015_bb0120","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.280.22.1936","article-title":"National consensus development panel on effective medical treatment of opiate addiction","volume":"280","author":"National Institute of Health","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0125","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00003495-200969050-00006","article-title":"Buprenorphine\/naloxone: a review of its use in the treatment of opioid dependence","volume":"69","author":"Orman","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0130","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000\u20132009","volume":"307","author":"Patrick","year":"2012","journal-title":"Jama"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0135","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/ADM.0b013e318287cfc9","article-title":"Opiate-dependent patients on a waiting list for methadone maintenance treatment are at high risk for mortality until treatment entry","volume":"7","author":"Peles","year":"2013","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.ypmed.2015.07.015_bb0140","series-title":"Problems of drug dependence","first-page":"261","article-title":"Treatment of four pregnant heroin addicts with buprenorphine: history and outcome","author":"Reisinger","year":"1995"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0145","author":"SAMHSA"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0150","series-title":"Results from the 2013 National Survey on Drug Use and Health: detailed tables in NSDUH","author":"SAMHSA","year":"2013"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0160","author":"SAMHSA"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0165","author":"SAMHSA"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0170","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.drugalcdep.2013.04.006","article-title":"Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes","volume":"132","author":"Schuman-Olivier","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ypmed.2015.07.015_bb0175","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamapsychiatry.2013.4450","article-title":"Access to treatment for opioid dependence in rural America: challenges and future directions","volume":"71","author":"Sigmon","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0180","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.addbeh.2011.01.026","article-title":"From Cat's Cradle to Beat the Reaper: getting evidence-based treatments into practice in spite of ourselves","volume":"36","author":"Sorensen","year":"2011","journal-title":"Addict. Behav."},{"issue":"267","key":"10.1016\/j.ypmed.2015.07.015_bb0185","first-page":"e1","article-title":"The obstetrical and neonatal impact of maternal opioid detoxification in pregnancy","volume":"209","author":"Stewart","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ypmed.2015.07.015_bb0190","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1517\/14656560903037168","article-title":"Opioid dependence treatment: options in pharmacotherapy","volume":"10","author":"Stotts","year":"2009","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.ypmed.2015.07.015_bb0195","author":"Vermont Child Health Improvement Program"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0200","author":"Vermont Department of Health"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0205","author":"Vermont Department of Health"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0210","author":"Vermont Department of Health"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0215","author":"Vermont Department of Health"},{"key":"10.1016\/j.ypmed.2015.07.015_bb0220","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/AOG.0000000000000640","article-title":"Buprenorphine and naloxone compared with methadone treatment in pregnancy","volume":"125","author":"Wiegand","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ypmed.2015.07.015_bb0225","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/10915810252866105","article-title":"Developmental toxicity of levo-alpha-acetylmethadol (LAAM) in tolerant rats","volume":"21","author":"York","year":"2002","journal-title":"Int. J. Toxicol."}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743515002315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743515002315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T16:37:52Z","timestamp":1620837472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743515002315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":44,"alternative-id":["S0091743515002315"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2015.07.015","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caring for pregnant opioid abusers in Vermont: A potential model for non-urban areas","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2015.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}